NIH Awards $19 Million to Institute for Clinical & Translational Science
UC Irvine is renowned for its exceptional research in the life sciences. With the establishment of the UC Irvine Institute for Clinical & Translational Science (ICTS), the University has made additional strides in translating its successes in the lab to advancing discoveries in clinical care. In recognition of this success, the National Institutes of Health (NIH) has recently awarded UC Irvine ICTS a $19 million dollar grant to continue transforming innovative discoveries into potential clinical therapeutics. The grant is a continuation of an initial award from the NIH received back in 2010.
There are only a total of 62 CTSA programs funded throughout the United States, making the UC Irvine ICTS a preeminent research consortium within Orange County. The Institute seek to address the many health challenges facing our nation by supporting multidisciplinary research among University faculty and promoting a friendly training environment for the Universities upcoming scientist.
“With this award, UC Irvine continues to forge a new direction for clinical research in the U.S. for a generation to come,” said Dr. Dan Cooper, institute director and professor and chair of the Department of Pediatrics.